These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks. Naldi L; Griffiths CE Br J Dermatol; 2005 Apr; 152(4):597-615. PubMed ID: 15840088 [TBL] [Abstract][Full Text] [Related]
5. Differing patterns of methotrexate use for psoriatic disease among dermatologists and rheumatologists. Dupuis EC; Bhole VM; Dutz JP Br J Dermatol; 2012 Aug; 167(2):448-50. PubMed ID: 22309601 [No Abstract] [Full Text] [Related]
6. Methotrexate use and monitoring in Switzerland and Denmark. Dam TN; Panizzon R; Jemec GB Dermatology; 2005; 210(3):253. PubMed ID: 15785063 [No Abstract] [Full Text] [Related]
7. Adverse drug interactions clinically important for the dermatologist. Andersen WK; Feingold DS Arch Dermatol; 1995 Apr; 131(4):468-73. PubMed ID: 7726592 [TBL] [Abstract][Full Text] [Related]
8. The use of infliximab in dermatology. Rott S; Mrowietz U J Dtsch Dermatol Ges; 2007 Aug; 5(8):655-60. PubMed ID: 17659038 [TBL] [Abstract][Full Text] [Related]
9. [Therapeutic strategies against psoriasis. Skin to hide -- and how do you free your patients from it]. Stiefelhagen P MMW Fortschr Med; 2007 Sep; 149(35-36):12-4. PubMed ID: 17944277 [No Abstract] [Full Text] [Related]
11. Evidence-based (S3) guidelines for the treatment of psoriasis vulgaris. Nast A; Kopp IB; Augustin M; Banditt KB; Boehncke WH; Follmann M; Friedrich M; Huber M; Kahl C; Klaus J; Koza J; Kreiselmaier I; Mohr J; Mrowietz U; Ockenfels HM; Orzechowski HD; Prinz J; Reich K; Rosenbach T; Rosumeck S; Schlaeger M; Schmid-Ott G; Sebastian M; Streit V; Weberschock T; Rzany B; ; J Dtsch Dermatol Ges; 2007 Jul; 5 Suppl 3():1-119. PubMed ID: 17615051 [TBL] [Abstract][Full Text] [Related]
12. [New data on the use of dimethylsulfoxide in experimental and clinical dermatology (a survey of the literature)]. Datskovskii BM; Zaks AS; Mitriukovskii LS Vestn Dermatol Venerol; 1973 Jan; 47(1):30-6. PubMed ID: 4575609 [No Abstract] [Full Text] [Related]
13. Psoriasis treatment 2003 at the new millennium: position paper on behalf of the authors. Menter MA; Krueger GC; Feldman SR; Weinstein GD J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S39-43. PubMed ID: 12894124 [No Abstract] [Full Text] [Related]
14. Use of conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists. Paul C; Ortonne JP J Eur Acad Dermatol Venereol; 2011 May; 25 Suppl 2():1. PubMed ID: 21388452 [No Abstract] [Full Text] [Related]
16. A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis. Bigby M Arch Dermatol; 2004 Mar; 140(3):347-8. PubMed ID: 15023778 [No Abstract] [Full Text] [Related]
17. Systemic therapy does not usually clear psoriasis, but treatment success does not require clearing. Feldman SR; Nijsten T; Margolis DJ; Rolstad T J Am Acad Dermatol; 2005 Jan; 52(1):140-1. PubMed ID: 15627096 [No Abstract] [Full Text] [Related]
18. A combination therapy of calcipotriol cream and PUVA reduces the UVA dose and improves the response of psoriasis vulgaris. Torras H; Aliaga A; López-Estebaranz JL; Hernández I; Gardeazabal J; Quintanilla E; Mascaró JM J Dermatolog Treat; 2004 Apr; 15(2):98-103. PubMed ID: 15204160 [TBL] [Abstract][Full Text] [Related]